The SARS-CoV-2 coronavirus has led to a pandemic with millions of people affected. The
present study finds that risk-factors for severe COVID-19 disease courses, ie male sex, older …

An under-explored target for SARS-CoV-2 is the S-adenosyl methionine (SAM)-dependent
methyltransferase Nsp14, which methylates the N7-guanosine of viral RNA at the 5′-end, …

Chikungunya virus (CHIKV) is an arthritogenic reemerging virus replicating in plasma
membrane-derived compartments termed “spherules.” Here, we identify the human …

Several cationic amphiphilic drugs (CADs) have been found to inhibit cell entry of filoviruses
and other enveloped viruses. Structurally unrelated CADs may have antiviral activity, yet the …

Inhibitors of bromodomain and extra-terminal proteins (iBETs), including JQ-1, have been
suggested as potential prophylactics against SARS-CoV-2 infection. However, molecular …

Hepatitis C virus (HCV) exploits the four entry factors CD81, scavenger receptor class B
type I (SR-BI, also known as SCARB1), occludin, and claudin-1 as well as the co-factor …

The HCV replication cycle is tightly associated with host lipid metabolism: Lipoprotein
receptors SR-B1 and LDLr promote entry of HCV, replication is associated with the formation of …

Libraries composed of licensed drugs represent a vast repertoire of molecules modulating
physiological processes in humans, providing unique opportunities for the discovery of host-…

Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …

Filoviruses infect a wide range of cell types with the exception of lymphocytes. The intracellular
proteins cathepsin B and L, two-pore channel 1 and 2, and bona fide receptor Niemann–…